Therapeutic and toxic effects of valproic acid metabolites

NA Shnayder, VV Grechkina, AK Khasanova… - Metabolites, 2023 - mdpi.com
Valproic acid (VPA) and its salts are psychotropic drugs that are widely used in neurological
diseases (epilepsy, neuropathic pain, migraine, etc.) and psychiatric disorders …

The pharmacogenomics of valproic acid

MM Zhu, HL Li, LH Shi, XP Chen, J Luo… - Journal of human …, 2017 - nature.com
Valproic acid is an anticonvulsant and mood-stabilizing drug used primarily in the treatment
of epilepsy and bipolar disorder. Adverse effects of valproic acid are rare, but hepatotoxicity …

Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro

U Fahrioğlu, Y Dodurga, L Elmas, M Seçme - Gene, 2016 - Elsevier
Novel and combinatorial treatment methods are becoming sought after entities in cancer
treatment and these treatments are even more valuable for pancreatic cancer. The scientists …

Assessment of interactions between cisplatin and two histone deacetylase inhibitors in MCF7, T47D and MDA-MB-231 human breast cancer cell lines–An …

A Wawruszak, JJ Luszczki, A Grabarska… - PLoS …, 2015 - journals.plos.org
Histone deacetylase inhibitors (HDIs) are promising anticancer drugs, which inhibit
proliferation of a wide variety of cancer cells including breast carcinoma cells. In the present …

Synthesis of chalcones with antiproliferative activity on the SH-SY5Y neuroblastoma cell line: Quantitative Structure–Activity Relationship Models

M Mellado, A Madrid, M Reyna… - Medicinal Chemistry …, 2018 - Springer
Chalcones are a group of molecules with a broad spectrum of biological activities, being
especially appealing for their antiproliferative effects on several cancer cell lines. For this …

From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer

M Pellegrino, E Ricci, R Ceraldi, A Nigro, D Bonofiglio… - Cancers, 2022 - mdpi.com
Simple Summary Although in the last decades the clinical outcome of cancer patients
considerably improved, the major drawbacks still associated with chemotherapy are the …

Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation

J Ma, LN Han, JR Song, XM Bai, JZ Wang, LF Meng… - Cellular Oncology, 2020 - Springer
Abstract Background Long non-coding RNAs (lncRNAs) are transcribed pervasively in the
genome and act to regulate chromatin remodeling and gene expression. Dysregulated …

[HTML][HTML] Isobolographic analysis demonstrates additive effect of cisplatin and HDIs combined treatment augmenting their anti-cancer activity in lung cancer cell lines

E Gumbarewicz, JJ Luszczki, A Wawruszak… - American Journal of …, 2016 - ncbi.nlm.nih.gov
Histone deacetylase inhibitors (HDIs) are a new class of drugs which affect the activity of
HDACs resulting in changed of acetylation in many proteins. HDIs can induce differentiation …

[HTML][HTML] Long non-coding RNA SNHG7 promotes neuroblastoma progression through sponging miR-323a-5p and miR-342-5p

J Jia, D Zhang, J Zhang, L Yang, G Zhao… - Biomedicine & …, 2020 - Elsevier
Dysregulation of long non-coding RNAs (lncRNAs) has been known to be relevant to the
progression of human cancers, including neuroblastoma (NB). Small nucleolar RNA host …

Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma

E Fang, J Wang, M Hong, L Zheng, Q Tong - Biochemical and biophysical …, 2019 - Elsevier
Altered glucose metabolism is a hallmark for cancer, which is characterized by a unique
metabolic phenotype known as Warburg effect or aerobic glycolysis. Emerging studies show …